Larvol Delta - The-place-of-acalabrutinibobinutuzumab-combination-in-the-firstline-treatment-of-patients-with-chronic-lymphocytic-leukemia

Calquence (acalabrutinib) - AstraZeneca

Gazyva (obinutuzumab) - Roche, Biogen

http://www.ncbi.nlm.nih.gov/pubmed/42724525

Agnieszka Szymczyk; Iwona Hus

Sep 12, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next